Hydrochlorothiazide Tablet
Product Images NDC 51655-831

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-831). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-831-26 (51655 831 26 Rev A 02 23)

Label for Hydrochlorothiazide Tablets, USP 25 mg, containing 90 tablets. The label indicates prescription use only and includes storage instructions to keep the product between 20°-25°C (68°-77°F). The labeler is Northwind Pharmaceuticals USA, Inc., and it includes a barcode, NDC number 51655-831-26, and repackaging information from Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Hctz Structural Formula (Image 1)

Chemical structure diagram displaying the molecular arrangement of Hydrochlorothiazide, highlighting its sulfonamide, chlorine-substituted aromatic ring, and heterocyclic sulfonamide ring features.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.